DrugsGeneral
Skip to content
available · hard-to-find medicines affordable · lowest price, highest quality legit · licensed partner only 7-day returns
Upload Rx
0 0
Sorafenib 200mg Tablet
Sourced directly from Natco Pharma

Sorafenib 200mg Tablet

Tablet · 120 Tablets per Box

$179.00 incl. taxes
Composition
Sorafenib
Manufacturer
Natco Pharma
Pack
120 Tablets per Box
No reviews yet Read reviews
Buy more, save more
In stock · 2 available
  • Order within -- and we dispatch today
  • Only 2 left. Once they are gone, restocking takes weeks.

About Sorafenib 200mg Tablet

Sorafenib 200 mg Tablet (Generic Nexavar)

Sorafenib 200 mg Tablet is a prescription multikinase inhibitor for HCC, RCC, and thyroid cancer. Generic equivalent of Nexavar (Bayer). Buy from a trusted supplier with worldwide shipping where permitted.

Product Information

Generic Name
Sorafenib 200 mg
Drug Class
Multikinase Inhibitor; RAF Kinase / VEGFR Inhibitor
Brand Reference
Nexavar (Bayer)
Indication
Hepatocellular carcinoma (HCC); advanced renal cell carcinoma (RCC); differentiated thyroid cancer refractory to radioactive iodine
Form
Film-coated Tablet
Strength
200 mg
Packing
120 Tablets per Box
Route
Oral
Prescription
Yes
Evidence
FDA-approved; EMA-approved; NICE-approved

Availability & Ordering

Patients and practitioners searching for Sorafenib 200 mg Tablet, Buy Sorafenib Online, Generic Nexavar 200 mg, Sorafenib Price USA UK, Multikinase Inhibitor for HCC will find genuine stock available for worldwide shipping where permitted by local import regulations. All orders are dispatched securely. Prescription products must be used under the supervision of a qualified healthcare professional.

How it works

Sorafenib targets RAF kinases (CRAF, BRAF) and receptor tyrosine kinases including VEGFR-2, VEGFR-3, PDGFR-beta, KIT, FLT3, and RET — providing dual anti-proliferative and anti-angiogenic mechanisms. Standard dose is 400 mg (two 200 mg tablets) twice daily. Sorafenib was the first oral therapy to demonstrate survival benefit in HCC, establishing targeted therapy as standard of care in advanced liver cancer across the USA, UK, Europe, and Australia.

Also in Cancer Care

View all
View all